ASCT invested in preclinical and clinical stage projects focusing on monogenic blood disorders11-50 Employees

B2C
Early Stage
Startup in initial stages

ASC Theraputics careers

ASCT invested in preclinical and clinical stage projects focusing on monogenic blood disorders

ASC Therapeutics is a division of Applied StemCell, Inc. which focuses on the development of curative therapeutic products that are enabled by its proprietary gene-editing platform, TARGATT™, and other gene-editing technologies. The company’s therapeutic development pipeline includes several preclinical and clinical-stage projects focusing on monogenic blood disorders.

Jobs